Bruker Corp. (NASDAQ:BRKR)
CAPS Rating:
The Company designs, manufactures, services and markets analytical and life science systems and associated products to address the needs of its customers in life science research, pharmaceutical, biotechnology and molecular diagnostics research.
RSS Headlines
Fool UK
Recs
Thank goodness I saw the "light" before closing out this position.
BRKR is consolidating *ITSELF*. Buying subsidiaries. Will be highly ACCRETIVE to earnings almost immediately.
In a sector I love. High insider ownership. Have a few lingering questions about management. Watch closely.